» Authors » Neil M Ampel

Neil M Ampel

Explore the profile of Neil M Ampel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 1638
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Donovan F, Ampel N, Thompson 3rd G
Infect Dis Clin North Am . 2024 Dec; 39(1):183-197. PMID: 39710556
Coccidioidomycosis is the clinical disease caused by the dimorphic pathogenic fungi Coccidioides immitis and C posadasii. The number of clinically recognized coccidioidomycosis cases continues to increase yearly including in regions...
2.
Donovan F, Thompson 3rd G, Blair J, Johnson R, Malo J, Albasha W, et al.
Chest . 2024 Dec; PMID: 39675520
Coccidioidomycosis, caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii, is recognized as an increasing threat both nationally and worldwide. This is in large part secondary to the expanding...
3.
Barker B, Thompson 3rd G, Ampel N
Open Forum Infect Dis . 2024 Jun; 11(6):ofae095. PMID: 38887487
A vaccine for coccidioidomycosis is likely to undergo trials in the near future. In this paper, we raise 4 questions that should be answered before its use and offer our...
4.
Shah P, Ampel N, Girardo M, Blair J
J Fungi (Basel) . 2023 Sep; 9(9). PMID: 37755009
Background: We sought to characterize the outcomes of patients with primary pulmonary coccidioidomycosis whose post-treatment complement fixation (CF) titer increased by more than 2 dilutions (serologic rebound) after discontinuation of...
5.
Gupta S, Ampel N, Klanderman M, Grill M, Blair J
J Fungi (Basel) . 2022 Nov; 8(11). PMID: 36354924
Introduction: Coccidioidal meningitis (CM) is the most lethal form of disseminated coccidioidomycosis. Current guidelines recommend fluconazole as initial therapy but there has been a paucity of data regarding failure of...
6.
Ashcherkin N, Gupta S, Huff D, Vikram H, Ampel N, Fischer K, et al.
Medicine (Baltimore) . 2022 Sep; 101(35):e30361. PMID: 36107584
The COVID-19 pandemic has disrupted medical care worldwide and caused delays in care for many illnesses and procedures unrelated to COVID-19; however, less clear is how it may have affected...
7.
Anwar F, Roxas B, Shehab K, Ampel N, Viswanathan V, Vedantam G
Emerg Microbes Infect . 2022 Jul; 11(1):1982-1993. PMID: 35880487
is a leading cause of healthcare-associated infections worldwide. Currently, there is a lack of consensus for an optimal diagnostic method for infection (CDI). Multi-step diagnostic algorithms use enzyme immunosorbent analysis...
8.
Thompson G, Ampel N, Blair J, Donovan F, Fierer J, Galgiani J, et al.
Clin Infect Dis . 2022 Jun; 75(4):555-559. PMID: 35717645
Central nervous system infection with Coccidioides spp. is fatal if untreated and complications occur even when therapy is directed by experienced clinicians. We convened a panel of clinicians experienced in...
9.
Huff D, Ampel N, Blair J
Mycopathologia . 2022 Apr; 187(2-3):199-204. PMID: 35428955
At a single medical center, we identified 60 cases of coccidioidomycosis that were coincident with COVID-19 infection. Among these, seven patients developed new or clinically progressive coccidioidomycosis. Receipt of dexamethasone...
10.
Messina J, Maziarz E, Galgiani J, Truong J, Htoo A, Heidari A, et al.
Contemp Clin Trials Commun . 2021 Oct; 24:100851. PMID: 34712863
Introduction: Coccidioidomycosis is a fungal infection endemic in the southwestern United States (US). Primary pulmonary coccidioidomycosis (PPC) is a leading cause of community-acquired pneumonia (CAP) in this region, although its...